Optimizing Functional Recovery After Breast Cancer Treatment
ConditionBreast Neoplasms
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMGH Institute of Health Professions
About this trial
The goal of this clinical trial is to determine the best way to promote participation in vocational, social, physical, and instrumental activities of daily living in people who have completed treatment for early stage breast cancer.
The main question it aims to answer is: Which of the intervention components, alone or in combination, most effectively promote participation in vocational, social, physical, and instrumental activities of daily living?
Participants will be asked to try one of 8 combination of three intervention components that have been shown to promote activity participation: (1) priority elicitation, (2) education, and (3) guided application involving goal setting, problem-solving and action planning.
Eligibility criteria
Qualifiers
Age of 18 years or older,
Diagnosed with Stage 1-3 breast cancer and within one year of completion of locoregional treatment and/or adjuvant therapy with curative intent and absence of disease recurrence,
Experiencing reduced participation (i.e., a score of > 10 on the Work and Social Adjustment Scale).
Disqualifiers
Non-English speaking.
Non-correctable hearing loss.
Moderate-severe cognitive impairment indicated by a score < 3 on a 6-item cognitive screener.
History of severe mental illness (i.e., schizophrenia, bipolar disorder), current major depressive disorder, active suicidal ideation, or active substance misuse documented within the medical record.
Trial design
Treatments tested in this trial
- Individually tailored education and guided application to promote activity participation
- Individually tailored guided application
- Individually tailored education
- Priority elicitation
- Static education and guided application
- Static guided application
- Static education
- Information
Treatment groups
352 Participants
are divided into 8 treatment groups8
Treatment groupsSee each treatment group below.
Sponsors and collaborators
MGH Institute of Health Professions
Lead sponsor
University of Alabama at Birmingham
Collaborator
University of South Alabama
Collaborator
Dartmouth-Hitchcock Medical Center
Collaborator
Source ClinicalTrials.gov